Diabetes complications

Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy

DiabetologiaPublished Cross-sectional study

Authors' conclusion

Our findings in individuals recently diagnosed with diabetes provide new evidence associating higher serum NFL levels with DSPN and peripheral nerve dysfunction. The present study advocates NFL as a potential biomarker for DSPN.

Study context

Population
Adults with T1D and T2D with known diabetes duration <1 year, prospective observational German Diabetes Study cohort
Participants
423 adults
Exposure
Higher vs lower serum NFL levels
Outcome
Association of serum NFL with DSPN (Toronto Consensus criteria)
Methodological detailsGerman Diabetes Study cohort, multiplex proximity extension assay
  • German Diabetes Study cohort
  • Multiplex proximity extension assay

Main finding

As reported in the abstract

DSPN per 1-normalised protein expression increase in serum NFL
  • RR (95% CI) per 1-normalised protein expression increase, 1.92 [1.50, 2.45], p<0.0001
  • Poisson regression adjusted for age, sex, waist circumference, height, HbA1c, known diabetes duration, diabetes type, cholesterol, eGFR, hypertension, CVD, lipid-lowering drugs and NSAID use

Observational data: associations, not effects.

Further findings

Diabetic sensorimotor polyneuropathy (DSPN) prevalence

DSPN prevalence
16%

Nerve function measures with higher serum NFL

Slower motor nerve conduction velocities
all p<0.0001
Slower sensory nerve conduction velocities
all p≤0.03
Lower sural sensory nerve action potential
P = 0.0004
Higher thermal detection threshold to warm stimuli, hand
P = 0.023
Higher thermal detection threshold to warm stimuli, foot
P = 0.004
  • Multivariable linear and quantile regression, adjusted

Other neurological biomarkers

No evidence for associations between other neurological biomarkers and DSPN or nerve function measures
  • Exploratory analyses

Serum NFL and age

Serum NFL levels increased with age

Original publication

Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy. Diabetologia. Published 6 December 2022. doi:10.1007/s00125-022-05846-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.